Both in Surgical Instruments
Boston Scientific vs ResMed
Over the past year BSX returned −57.4% and RMD returned −7.6%; their daily moves had a correlation of 0.21.
BSX −57.4% RMD −7.6%Growth of $1, one year, split-adjusted
| Metric | BSX | RMD |
|---|---|---|
| Price | $41.98 | $229.94 |
| Market cap | $60.84B | $32.34B |
| Today | −1.66% | −9.05% |
| 1 month | −2.9% | +4.0% |
| 6 months | −25.7% | +12.2% |
| Year to date | −56.0% | −4.5% |
| 1 year | −58.1% | −9.3% |
| Revenue growth (YoY) | +7.5% | +5.9% |
| Gross margin | 70.7% | 61.5% |
| Net margin | 16.7% | 29.6% |
| P/E (TTM) | 16.6× | 20.3× |
| Price / sales | 2.9× | 5.6× |
| Net cash | -$12.09B | $601.1M |
| Dividend yield | — | 1.15% |
| Volatility (60d) | 34.7% | 32.9% |
| Short % of float | 2.8% | 8.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).